Profound Medical
PROF
34 hedge funds and large institutions have $91.7M invested in Profound Medical in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 14 increasing their positions, 6 reducing their positions, and 4 closing their positions.
281% more call options, than puts
Call options by funds: $293K | Put options by funds: $77K
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
158% more capital invested
Capital invested by funds: $35.6M → $91.7M (+$56.2M)
133% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 6
1.53% less ownership
Funds ownership: 42.12% → 40.59% (-1.5%)
3% less funds holding
Funds holding: 35 → 34 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$1.53M |
| 2 |
Fidelity International
Hamilton,
Bermuda
|
+$656K |
| 3 |
RA
Royce & Associates
New York
|
+$563K |
| 4 |
TDC
Thompson Davis & Co
Richmond,
Virginia
|
+$277K |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$211K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$2.96M |
| 2 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$588K |
| 3 |
LBA
Letko, Brosseau & Associates
Montreal,
Quebec, Canada
|
-$410K |
| 4 |
CM
Caption Management
Oklahoma City,
Oklahoma
|
-$247K |
| 5 |
CAG
Crestwood Advisors Group
Boston,
Massachusetts
|
-$22.9K |
PROF Hedge Fund Activity: Q4 2022 in Review
34 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Profound Medical (PROF) for Q4 2022, worth a combined $91.7M — up 158% from $35.6M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of PROF and 3 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 14 added.
The largest buyer was Raymond James Financial Services Advisors, adding an estimated $1.53M. The largest seller was Deerfield Management, exiting entirely with an estimated $2.96M sold.
- 34 institutional investors held Profound Medical (PROF) as of Q4 2022, down from 35 in Q3 2022.
- Funds reported $91.7M of Profound Medical stock for Q4 2022, up 158% quarter-over-quarter.
- 3 funds opened new Profound Medical positions in Q4 2022 and 4 closed out, a net change of -1 holder.
- The largest Profound Medical buyer in Q4 2022 was Raymond James Financial Services Advisors, an estimated $1.53M added.
- The largest Profound Medical seller in Q4 2022 was Deerfield Management, an estimated $2.96M sold.
Based on aggregated 13F filings for Q4 2022.